Journal
ACTA DERMATO-VENEREOLOGICA
Volume 103, Issue -, Pages -Publisher
ACTA DERMATO-VENEREOLOGICA
DOI: 10.2340/actadv.v103.6485
Keywords
social stigma; skin diseases; medical psychology; multicentre study
Categories
Ask authors/readers for more resources
An observational cross-sectional study quantified perceived stigmatization and identified its predictors among patients with a wide range of skin diseases. Patients experienced higher levels of perceived stigmatization compared to controls, and factors such as age, gender, general health, and disease severity were associated with stigmatization.
Perceived stigmatization places a large psychosocial burden on patients with some skin conditions. Little is known about the experience of stigmatization across a wide range of skin diseases. This observational cross-sectional study aimed to quantify perceived stigmati-zation and identify its predictors among patients with a broad spectrum of skin diseases across 17 Euro-pean countries. Self-report questionnaires assessing perceived stigmatization and its potential predictors were completed by 5,487 dermatology outpatients and 2,808 skin-healthy controls. Dermatological diagnosis, severity, and comorbidity were clinician-assessed. Pa-tients experienced higher levels of perceived stigma-tization than controls (p <0.001, d = 0.26); patients with psoriasis, atopic dermatitis, alopecia, and bul-lous disorders were particularly affected. Multivariate regression analyses showed that perceived stigmati-zation was related to sociodemographic (lower age, male sex, being single), general health-related (higher body mass index, lower overall health), disease -rela-ted (higher clinician-assessed disease severity, pre-sence of itch, longer disease duration), and psycholo-gical (greater distress, presence of suicidal ideation, greater body dysmorphic concerns, lower appearance satisfaction) variables. To conclude, perceived stig-matization is common in patients with skin diseases. Factors have been identified that will help clinicians and policymakers to target vulnerable patient groups, offer adequate patient management, and to ultimately develop evidence-based interventions.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available